Hypomagnesaemia and its determinants in a contemporary primary care cohort of persons with type 2 diabetes.
Femke WaandersRobin P F DullaartMichel J VosSteven H HendriksHarry van GoorHenk J G BiloPeter Ruben van DijkPublished in: Endocrine (2019)
Hypomagnesaemia was present in 9.6% of T2DM patients treated in primary care. This percentage is remarkably lower than reported previously, possibly due to the unselected nature of our population. Concerning T2DM-related factors, only BMI, HbA1c and the use of metformin, sulfonylurea derivatives and DPP4 inhibitors correlated negatively with magnesium concentrations.